Noninvasive real-time monitor for diagnosing and defining dry eye syndrome

IR-MED developed a breakthrough light based technology for diagnosing, with no touch, dry eye syndrome and defining the individual composition of the tear film and its stability, in just few seconds. To this end, IR-MED measures tear evaporation time and tear film composition without touching the eye globe in a glimpse.

Dry eye syndrome, known as keratoconjunctivitis sicca, is a multifactorial malfunction of tears production and stability mechanisms or the eye surface, which are crucial for the normal interphase between the eye front and its surrounding. This results in eye irritation, redness, blurred vision, visual disturbance, and even scarring of the cornea. Dry eye syndrome is suspected from symptoms and eye examination by a slit lamp, but clinical and laboratory studies to determine quantity and the quality of the tears are necessary.
Among them are the Schirmers test that measures the amount of tears, the tear breakup time test which determines how long it takes for tears to evaporate from the eye surface, and a host of biological assays which quantify the three main components of the tears, lipids, aqueous and mucous. These all are costly, complicated and time consuming to perform and are not available even in advanced clinics. IR-MED technology will perform these tests instantaneously to aid the physician in decision making in the diagnosis and treatment of dry eye syndrome.


IR-MED products are for investigational purposes only. IR-MED products are not approved to be used on humans.